Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-16-145821

Chief Financial Officer sold 5,000 shares at an average $17.47 ($87,325)

From the SEC's structured data for this filing

Trades in this filing

MCGRATH JOHN · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2016-10-11 Sale : show line 1 in the form −2,500 $18.52 $46,300 96,823 D
2016-10-12 Sale : show line 2 in the form −2,500 $16.41 $41,025 94,323 D
Open-market sales · 5,000 sh · avg $17.47 · $87,325
Loading xslF345X03/doc4.xml…